Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D
December 15, 2010Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development
Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Publicis makes German digital healthcare acquisition
December 15, 2010Medical Communications Digital District, Publicis Groupe, Publicis Healthware International, healthcare communications agency, medical communications, publicis
The healthcare arm of French communications giant Publicis Groupe has bought a German agency specialising in digital health comms to …
NHS cuts will push health service “to the limit”
December 14, 2010Health Select Committee, King’s Fund, NHS, NHS Confederation, NHS reforms, king's fund, social services
MPs have issued a stark warning on the impact of Government spending plans on the England’s health services, saying they …
Bayer invests 35m euros in biologics production
December 14, 2010Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production
Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …
GSK buys sports nutrition company for £162m
December 14, 2010Sales and Marketing GSK, GlaxoSmithKline, Maximuscle, Maxinutrition, consumer healthcare, sports nutrition
GlaxoSmithKline has acquired UK sports nutrition firm Maxinutrition for £162 million to help broaden its consumer portfolio. The company already …
Pfizer withdraws hypertension drug Thelin
December 14, 2010Sales and Marketing PAH, Pfizer, Thelin, liver damage, liver toxicity, patient safety, pulmonary arterial hypertension, sitaxentan
Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …
McNeil recalls Rolaids on particle contamination
December 14, 2010Manufacturing and Production J&J, JJ, McNeil, Rolaids, particulate contamination, pharmaceutical manufacturing, product recalls
Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …
Sopharma breaks ground on 16th manufacturing plant
December 14, 2010Manufacturing and Production Bulgaria, Sopharma, oral dosage forms, pharma manufacturing, pharmaceutica production
Bulgarian drugmaker Sopharma says it will press ahead with plans to build a new production plant for oral dosage forms …
Sanofi extends Genzyme share deal deadline
December 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
Amgen and Actelion meet to “talk takeover”
December 13, 2010Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover
Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
Novartis pulls Zometa submission after breast cancer failure
December 13, 2010Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic
Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
China to ‘overtake US in innovation by 2020’
December 13, 2010Research and Development, Sales and Marketing AstraZeneca, China, India, innovation
China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
Bristol-Myers Squibb appoints new UK general manager
December 13, 2010Manufacturing and Production, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, appointment, recruitment, sales and marketing
Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …
West Pharma cuts staff as profits are pressured
December 13, 2010Manufacturing and Production West Pharma, drug delivery systems, job cuts, pharma packaging, pharmaceutical manufacturing, plastic packaging
West Pharmaceutical Services has taken the axe to its manufacturing facilities in the US and UK in order to cut …
Contract manufacturing driving Indian bulk drugs market
December 13, 2010Manufacturing and Production Cygnus, Drug Master Files, India, Indian pharmaceutical industry, contract manufacturing
The Indian bulk drug industry is expected to expand at an annual growth rate of 21% to reach $16.91 billion …
Pfizer: WikiLeaks claims “preposterous”
December 10, 2010Research and Development Nigeria, Pfizer, Trovan, WikiLeaks, ceftriaxone, clinical trial safety, industry reputation
Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …
Double blow to Pfizer’s emerging markets strategy
December 10, 2010Business Services, Sales and Marketing David Simmons, Ian Read, Jean-Michel Halfon, Jeffrey Kindler, Pfizer, Steve Yang, emerging pharma markets, recruitment
Pfizer has lost two senior executives with key roles in its emerging markets strategy. The departure of the company’s head …
Hormone therapy drugs ‘increase heart disease risk’
December 10, 2010Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen
Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …
Elan names Robert Ingram as new chairman
December 10, 2010Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing
Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …
Valuing medicines and NHS reform – the ABPI view
December 10, 2010Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing
For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
